Haibo Liu

Dr. Haibo Liu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2020 in PeerJ
Verified
Journal Article
Open access
PDF file
XYXiaolin Yang
Xiaolin Yang
HSHongzhi Sun
Hongzhi Sun
YSYing Song
Ying Song
LYLi Yang
Li Yang
HLHaibo Liu
Haibo Liu
Background: Spindle pole body component 25 (SPC25) plays a vital role in many cellular processes, such as tumorigenesis. However, the clinical significance of SPC25 in hepatocellular carcinoma (HCC) has not been investigated. This study aimed to explore the expression patterns of SPC25 in HCC and non-neoplastic tissues and to investigate the diagnostic and prognostic values of SPC25. Method: The expression of SPC25 was examined in 374 HCC issues and 50 non-neoplastic tissues from The Cancer Genome Atlas (TCGA) cohort. The diagnostic and prognostic values of SPC25 were analyzed via receiver operating characteristic (ROC) curve and survival analyses, respectively. Univariate and multivariate Cox regression analyses were used to identify the prognostic factors and to establish a nomogram. The diagnostic and prognostic values were further validated in an external cohort from the International Cancer Genome Consortium (ICGC) database. Results: The expression of SPC25 in HCC tissues was significantly higher than that in normal tissues in both cohorts (all P < 0.001). The ROC curve analysis indicated that SPC25 expression has high diagnostic value in HCC with area under the curve (AUC) value of 0.969 (95% confidence interval [CI] [0.948–0.984]) and 0.945 (95% CI [0.920–0.965]) for TCGA and ICGC cohorts, respectively. Patients with HCC exhibiting high SPC25 expression were associated with worse prognosis than those exhibiting low SPC25 expression in both cohorts (all P < 0.001). SPC25 was independently associated with overall survival in both cohorts (all P < 0.001). The concordance indices of the nomogram for predicting overall survival in TCGA and ICGC cohorts were 0.647 and 0.805, respectively, which were higher than those of the American Joint Committee on Cancer (AJCC) staging system. Conclusion: SPC25 was upregulated in HCC and independently predicted poor overall survival of patients with HCC. Therefore, SPC25 is an effective diagnostic and prognostic biomarker for HCC. An SPC25-based nomogram was more accurate and useful than the AJCC staging system to predict prognosis of HCC.

24 October 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
DCDanyang Chang
Danyang Chang
FZFuhong Zheng
Fuhong Zheng
LZLei Zhu
Lei Zhu
HLHaibo Liu
Haibo Liu
Background: Pulmonary embolism (PE) is a serious condition that is frequently encountered in clinical practice. It has been demonstrated that the body’s physiological responses to platelet activation can lead to significant complications, including pulmonary hypertension, bronchoconstriction, and right heart failure. Albumin is recognized as a composite indicator of acute-phase reactant proteins, which have osmotic and anti-inflammatory properties, as well as nutrient and metabolic imbalance. Albumin demonstrates independent prognostic value in a variety of diseases. The platelet-to-albumin ratio (PAR) has emerged as a reliable predictor of mortality and complications based on systemic inflammation in a number of diseases. However, studies on the relationship between PAR and adverse outcomes in critically ill patients with pulmonary embolism are limited. Thus, this study aimed to investigate whether PAR could be a useful indicator for assessing pulmonary embolism outcomes. Methods: The clinical data of 1163 patients with critical pulmonary embolisms were extracted from the MIMIC-IV (version 2.2) database. The study population was categorized into four groups according to PAR quartiles. The primary regression was 28-day ICU mortality, while the secondary regressions were 7-d and 14-d ICU mortality. Restricted cubic splines, Cox proportional hazards regression, and Kaplan-Meier curves were used to explore the relationship between PAR and adverse outcomes. We assessed the predictive power of PAR using the Boruta algorithm and built predictive models using machine learning algorithms. Results: Data from 1163 patients diagnosed with pulmonary embolism were analyzed. Lower PAR was significantly associated with an increased risk of 7-d ( p < 0.001), 14-d ( p < 0.001), and 28-d ( p < 0.005) ICU mortality compared with higher PAR. The restricted cubic spline curve revealed an “L-shaped” relationship between PAR and survival, suggesting that an increase in PAR is linked to a reduced risk of adverse events. Patients with lower PAR had a higher risk of death within 7, 14, and 28 days in the ICU compared to those with higher PAR ( p < 0.05). Boruta feature selection showed PAR had a higher Z score, and the model built using the Conditional Inference Trees algorithm had the best performance (AUC = 0.623). Conclusion: PAR showed an “L”-shaped relationship with all-cause mortality at 7, 14, and 28 days in critically ill patients. Low PAR was significantly associated with an increased risk of adverse events, suggesting that PAR may be a predictor of adverse outcomes in patients with pulmonary embolisms.

25 August 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YLYihang Li
Yihang Li
FZFuhong Zheng
Fuhong Zheng
YBYajuan Bai
Yajuan Bai
YYYang Yu
Yang Yu
RZRan Zhang
Ran Zhang
HLHaibo Liu
Haibo Liu
As the largest organ of the human body, the skin is essential for maintaining systemic homeostasis; however, it remains highly susceptible to injury and wound formation, posing a significant clinical and economic burden. Wound healing is a complex, tightly coordinated process that progresses through overlapping phases of hemostasis, inflammation, proliferation, and tissue remodeling. Exosomes, nanoscale extracellular vesicles (50–150 nm in diameter) secreted by various cell types, have emerged as critical mediators of intercellular communication. Laden with bioactive molecules such as proteins, RNAs, and lipids, exosomes can partially replicate the regenerative functions of their parent cells. Among various types of exosomes, mesenchymal stem cell-derived exosomes (MSC-Exos) have become the most clinically translatable research direction in the field of skin wound repair due to their biological functions similar to those of their parent stem cells, low immunogenicity, and advantages as a cell-free therapy. This review focuses on MSC-Exos and systematically summarizes the roles and underlying mechanisms of adipose-derived stem cell exosomes, bone marrow mesenchymal stem cell exosomes, human umbilical cord mesenchymal stem cell exosomes, antler stem cell exosomes, human urine-derived stem cell exosomes, and induced pluripotent stem cell exosomes in cutaneous wound repair. Additionally, to broaden the diversity of therapeutic sources, plant-derived exosome-like nanovesicles are also discussed as an emerging perspective. Current evidence indicates that these vesicles facilitate wound healing and attenuate scarring by modulating multiple signaling pathways, thereby promoting cell proliferation, migration, angiogenesis, and extracellular matrix remodeling. Nevertheless, challenges in isolation, purification, optimization, standardization, and quality control continue to hinder their broad clinical translation. Despite these obstacles, exosomes represent a promising therapeutic strategy for cutaneous wound healing.